Strides Pharma Science Limited — Mycophenolate Exporter Profile
Indian Pharmaceutical Exporter · #2 for Mycophenolate · $9.7M export value · DGFT Verified
Strides Pharma Science Limited is the #2 Indian exporter of Mycophenolate with $9.7M in export value and 193 verified shipments. Strides Pharma Science Limited holds a 2.9% market share in Mycophenolate exports across 3 countries. The company exports 42 pharmaceutical products worth $179.3M across 20 therapeutic categories.
Strides Pharma Science Limited — Mycophenolate Export Profile: Buyers & Destinations
Where Does Strides Pharma Science Limited Export Mycophenolate?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $8.9M | 182 | 97.6% |
| MALAYSIA | $214.0K | 5 | 2.4% |
| UNITED ARAB EMIRATES | $59 | 6 | 0.0% |
Strides Pharma Science Limited exports Mycophenolate to 3 countries. The largest destination is UNITED STATES accounting for 97.6% of Strides Pharma Science Limited's Mycophenolate shipments, followed by MALAYSIA (2.4%) and UNITED ARAB EMIRATES (0.0%). These destinations reflect Strides Pharma Science Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Mycophenolate from Strides Pharma Science Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| STRIDES PHARMA INC | UNITED STATES | $3.6M | 73 |
| STRIDES PHARMA INC, | UNITED STATES | $3.1M | 63 |
| AVET PHARMACCEUTICALS INC., | UNITED STATES | $1.4M | 29 |
| AVET PHARMACCEUTICALS INC | UNITED STATES | $499.1K | 11 |
| STRIDES PHARMA INC.. | UNITED STATES | $200.0K | 4 |
| TO PUBLIC BANK BERHAD | MALAYSIA | $164.0K | 4 |
| UPS SCS | UNITED STATES | $100.0K | 2 |
| UNIMED SDN BHD | MALAYSIA | $50.0K | 1 |
| JULPHAR ( GULF PHARAMACEUTICAL INDU | UNITED ARAB EMIRATES | $29 | 3 |
| JULPHAR GULF PHARMACEUTICAL INDUSTR | UNITED ARAB EMIRATES | $29 | 3 |
Strides Pharma Science Limited supplies Mycophenolate to 10 buyers globally. The largest buyer is STRIDES PHARMA INC (UNITED STATES), followed by STRIDES PHARMA INC, (UNITED STATES) and AVET PHARMACCEUTICALS INC., (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Mycophenolate Export Value and How Much Does Strides Pharma Science Limited Contribute?
India exported $86.9M worth of Mycophenolate through 2,529 shipments from 167 suppliers to 100 countries, serving 512 buyers globally. Strides Pharma Science Limited contributes $9.7M to this total, accounting for 2.9% of India's Mycophenolate exports. Strides Pharma Science Limited ships Mycophenolate to 3 countries through 10 buyers.
What Is the Average Shipment Value for Strides Pharma Science Limited's Mycophenolate Exports?
Strides Pharma Science Limited's average Mycophenolate shipment value is $50.0K per consignment, based on 193 shipments totaling $9.7M. The largest destination is UNITED STATES (97.6% of Strides Pharma Science Limited's Mycophenolate exports).
How Does Strides Pharma Science Limited Compare to Other Indian Mycophenolate Exporters?
Strides Pharma Science Limited ranks #2 among 167 Indian Mycophenolate exporters with a 2.9% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($22.7M), ALKEM LABORATORIES LIMITED ($17.8M), EMCURE PHARMACEUTICALS LIMITED ($14.0M). Strides Pharma Science Limited processed 193 shipments to 3 destination countries.
What Mycophenolate Formulations Does Strides Pharma Science Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MYCOPHENOLATE MOFETIL TABLETS USP (500MG | $650.0K | 13 |
| Mycophenolate Mofetil Tablets USP [500mg | $500.0K | 10 |
| MYCOPHENOLATE MOFETIL CAPSULES USP 250MG HARD GELATIN US EACH CAPSULE CONTAINS MYCOPHENOLATE MOFETIL USP 250MG | $201.2K | 5 |
| MYCOPHENOLATE MOFETIL TABLETS USP 500MG | $200.0K | 4 |
| MYCOPHENOLATE MOFETIL TABLETS USP [500MG] [FC] [US] - ANDA NO : 90456 NDC NO : 23155-836-01. | $200.0K | 4 |
| Mycophenolate Mofetil Capsules USP [250m | $150.0K | 3 |
| MYCOPHENOLATE MOFETIL TABLETS USP(500MG) | $150.0K | 3 |
| MYCOPHENOLATE MOFETIL TABLETS USP 500MG FC US EACH FILM COATED TABLET CONTAINS MYCOPHENOLATE MOFETIL USP 500MG | $150.0K | 3 |
| MYCOPHENOLATE MOFETIL TABLETS USP [500MG] [FC] [US] ANDA NO : 90456 NDC NO : 64380#725#06. 58,272.00 X 100'SNOS | $150.0K | 3 |
| MYCOPHENOLATE MOFETIL TABLETS USP [500MG] [FC] [US] 38784.00X 100'SNOS | $150.0K | 3 |
Strides Pharma Science Limited exports 129 distinct Mycophenolate formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MYCOPHENOLATE MOFETIL TABLETS USP (500MG with 13 shipments worth $650.0K.
Regulatory Requirements: Exporting Mycophenolate to Key Markets
What Strides Pharma Science Limited must comply with to export Mycophenolate to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Strides Pharma Science Limited Compare to Nearest Mycophenolate Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | EMCURE PHARMACEUTICALS LIMITED | $14.0M | 299 | 23 | $46.7K |
| 4 | SANDOZ PRIVATE LIMITED | $10.2M | 204 | 8 | $50.0K |
| 2 | STRIDES PHARMA SCIENCE LIMITED ★ | $9.7M | 193 | 3 | $50.0K |
| 6 | CONCORD BIOTECH LIMITED | $6.0M | 119 | 8 | $50.0K |
| 8 | MYLAN LABORATORIES LIMITED | $1.8M | 36 | 4 | $50.0K |
Strides Pharma Science Limited ranks #2 among 167 Indian Mycophenolate exporters. Average shipment value of $50.0K compared to the market average of $520.1K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and SANDOZ PRIVATE LIMITED.
Which Indian Ports Ship Mycophenolate Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 464 | 18.3% |
| NHAVA SHEVA SEA (INNSA1) | 308 | 12.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 229 | 9.1% |
| JNPT/ NHAVA SHEVA SEA | 135 | 5.3% |
| DELHI AIR | 115 | 4.5% |
| AHEMDABAD AIR ACC (INAMD4) | 108 | 4.3% |
| MUNDRA SEA | 97 | 3.8% |
| BANGALORE ICD | 97 | 3.8% |
What Other Immunosuppressants Products Does Strides Pharma Science Limited Export?
Strides Pharma Science Limited also exports these immunosuppressants products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Strides Pharma Science Limited's Mycophenolate Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Strides Pharma Science Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, a critical shipping route. This situation has resulted in higher shipping costs and potential delays, impacting the timely delivery of pharmaceutical products to key markets.
Conversely, ongoing trade tensions between the U.S. and China have opened avenues for Indian pharmaceutical companies. The U.S. is increasingly looking towards India as a reliable supplier of generic drugs, providing companies like Strides with opportunities to expand their footprint in the American market.
In the European Union, the implementation of the Falsified Medicines Directive (FMD) has imposed stringent compliance requirements. Indian exporters must adapt to these regulations to maintain market access. However, the recent India–EU Free Trade Agreement, concluded in January 2026, aims to eliminate tariffs on pharmaceuticals, potentially enhancing the competitiveness of Indian exporters in the European market. (en.wikipedia.org)
Strides Pharma Science Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Strides Pharma Science Limited has demonstrated a commitment to quality, as evidenced by the U.S. FDA's classification of its Chestnut Ridge facility in New York as "Voluntary Action Indicated" following an inspection in December 2025. This classification indicates that while some observations were noted, they are not expected to lead to regulatory action, reflecting the facility's adherence to Good Manufacturing Practices. (economictimes.indiatimes.com)
Such regulatory approvals are crucial for sustaining and expanding market presence, particularly in stringent markets like the U.S. and the EU. Continuous investment in compliance and quality assurance will be essential for Strides to navigate the evolving regulatory landscape effectively.
About Strides Pharma Science Limited
Strides Pharma Science Limited exports 42 products worth $179.3M. Beyond Mycophenolate, top products include Ibuprofen, Rosuvastatin, Gabapentin, Vancomycin, Prednisone. View the complete Strides Pharma Science Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Mycophenolate — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Mycophenolate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Strides Pharma Science Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 193 individual customs records matching Strides Pharma Science Limited exporting Mycophenolate, covering 129 formulations to 3 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 100+ countries, 512+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Mycophenolate Export Data from Strides Pharma Science Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Strides Pharma Science Limited's Mycophenolate exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Strides Pharma Science Limited
Full Company Profile →
42 products · $179.3M total trade · 20 categories
Mycophenolate Stats
Company Overview
Top Products by Strides Pharma Science Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Strides Pharma Science Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mycophenolate. For current shipment-level data, contact TransData Nexus.